Cargando…
ODP142 Concentric Reversible Visual Field Loss, Nyctalopia and Dyschromatopsia With Ezetimibe Therapy - A Case Report
BACKGROUND: Ezetimibe is a lipid lowering agent that selectively inhibits intestinal cholesterol absorption. It is clinically indicated in patients with hypercholesterolemia in combination with statin or as monotherapy in patients who are contraindicated or intolerant to statin. Musculoskeletal and...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625016/ http://dx.doi.org/10.1210/jendso/bvac150.493 |